HIV/AIDS Treatment and Care : Clinical protocols for the European ...

management of hepatitis b and hiv coinfection
IV. Suggested minimum data to be collected at the clinical
level
The suggested minimum data to be collected are important in the development of key indicators on
access to treatment and its success. Such indicators assist managers in decision-making on ways to
strengthen and expand these services to all those in need.
The following data should be collected at each clinical facility on a regular basis (e.g. monthly,
quarterly or semi-annually):
• number of HIV patients (“seen for care” – this will be the denominator for the data below);
• number of HIV patients coinfected with HBV (HbsAg-positive);
• number of HIV-positive patients with active hepatitis;
• number of HIV-positive patients with active hepatitis receiving:
° HAART with 3TC and/or TDF;
° ART without 3TC and/or TDF;
° exclusively on hepatitis B treatment (e.g. IFN or ADF);
• number of HIV-infected patients vaccinated against HBV; and,
• number of HBV/HIV coinfected patients who have died (in a given time period) including cause
of death (e.g. liver-related deaths, HIV/AIDS related mortality or non-HIV/AIDS related mortality
such as accident, overdose or suicide).
295